MIMEDX GROUP, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $245.0m
$321.1m +31.07%
$359.1m +11.82%
$299.3m -16.67%
$248.2m -17.05%
$258.6m +4.18%
$267.8m +3.57%
$321.5m +20.03%
$348.9m +8.52%
$418.6m +19.99%
$355.2m -15.16%
Cost of Revenue $32.4m
$35.2m +8.68%
$36.4m +3.31%
$43.1m +18.40%
$39.3m -8.71%
$43.3m +10.05%
$48.3m +11.63%
$54.6m +13.08%
$60.1m +9.96%
$73.0m +21.54%
$75.1m +2.89%
Gross Profit $212.6m
$285.9m +34.48%
$322.7m +12.87%
$256.2m -20.62%
$208.9m -18.45%
$215.3m +3.08%
$219.5m +1.95%
$266.8m +21.55%
$288.8m +8.23%
$345.6m +19.67%
$280.1m -18.97%
Interest Income (Expense), Net ($4.7m)
($7.9m) -68.67%
($5.0m) +37.29%
($5.0m) -0.72%
($6.5m) -28.73%
$1.0m +115.58%
$2.9m +191.55%
Research and Development Expense $12.0m $17.9m $15.8m $11.1m $11.7m $17.3m $22.8m $12.7m $12.3m $15.1m $15.4m
Selling, General and Administrative Expense $180.0m $220.1m $258.5m $198.2m $181.0m $198.4m $208.8m $211.1m $225.1m $266.2m $255.1m
Amortization of Intangible Assets $2.1m $1.7m $1.0m $1.0m $1.1m $820k $701k $762k $765k $439k
Operating expenses:
Operating Income (Loss) $18.4m
$46.2m +150.59%
($3.9m) -108.49%
($21.2m) -439.25%
($45.4m) -114.55%
($5.0m) +88.91%
($25.0m) -395.95%
$37.1m +248.64%
$58.9m +58.60%
$63.9m +8.53%
$8.8m -86.30%
Interest Expense $339k ($890k)
Other Nonoperating Income (Expense) ($87k) $527k $283k ($3k) ($23k) ($4k) ($26k) ($565k) ($558k)
Interest Expense (non-operating) $3.9m $1.8m ($890k)
Interest Income (Expense), Nonoperating, Net $5.0m $6.5m ($1.0m) $2.9m
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $25.6m $61.5m ($10.0m) ($30.0m) $30.6m $57.3m $66.3m $11.5m
Current Income Tax Expense (Benefit) $6.1m $7.0m $1.0m ($5k) ($12.3m) $247k $206k $998k $2.8m $9.0m $5.3m
Income Tax Expense (Benefit) $6.1m ($19.6m) $26.6m ($5k) ($12.3m) $247k $206k ($36.8m) $15.3m $17.7m $5.3m
Net Income (Loss) Attributable to Parent $12.0m
$64.7m +440.56%
($30.0m) -146.32%
($25.6m) +14.67%
($49.3m) -92.67%
($10.3m) +79.13%
($30.2m) -193.60%
$58.2m +292.83%
$42.4m -27.15%
$48.6m +14.52%
$6.2m -87.16%
Net Income (Loss) Available to Common Stockholders, Basic $12.0m
$64.7m +440.56%
($30.0m) -146.32%
($25.6m) +14.67%
($83.3m) -225.75%
($16.4m) +80.29%
($36.8m) -123.96%
$55.8m +251.71%
$42.0m -24.73%
$48.6m +15.67%
$6.2m -87.16%
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic $12.0m $64.7m ($30.0m) ($25.6m) ($49.3m) ($10.3m) ($30.2m) $55.8m $42.0m $48.6m $6.2m
Preferred Stock Dividends and Other Adjustments $6.6m $11.6m $0 $0
Preferred Stock Dividends, Income Statement Impact $6.8m $0 $0
Earnings Per Share, Basic $0.11 $0.61 ($0.28) ($0.24) ($0.77) ($0.15) ($0.33) $0.40 $0.29 $0.33 $0.05
Earnings Per Share, Diluted $0.11 $0.56 ($0.28) ($0.24) ($0.77) ($0.15) ($0.33) $0.37 $0.28 $0.32 $0.04
Income (Loss) from Continuing Operations, Per Basic Share $0 $1 ($0) ($0) ($1) ($0) ($0) $0 $0 $0
Income (Loss) from Continuing Operations, Per Diluted Share $0 $1 ($0) ($0) ($1) ($0) ($0) $0 $0 $0
Weighted Average Number of Shares Outstanding, Basic 105.9m 106.1m 105.6m 106.9m 108.3m 110.4m 112.9m 116.5m 147.0m 147.8m 148.1m
Weighted Average Number of Shares Outstanding, Diluted 112.4m 116.1m 105.6m 106.9m 108.3m 110.4m 112.9m 146.0m 149.0m 149.7m 149.0m
Additional Financial Items
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0 $392k
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $25.6m $61.5m $10.0m $30.0m $67.4m $42.0m $48.6m
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent $2.0m $10.2m ($9.2m) $421k $0